A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic
Abstract Background The coronavirus pandemic (Covid-19) presents a variety of challenges for ongoing clinical trials, including an inevitably higher rate of missing outcome data, with new and non-standard reasons for missingness. International drug trial guidelines recommend trialists review plans f...
Main Authors: | Suzie Cro, Tim P. Morris, Brennan C. Kahan, Victoria R. Cornelius, James R. Carpenter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12874-020-01089-6 |
Similar Items
-
Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
by: Brennan C. Kahan, et al.
Published: (2020-09-01) -
Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool
by: Suzie Cro, et al.
Published: (2023-07-01) -
Planning a method for covariate adjustment in individually randomised trials: a practical guide
by: Tim P. Morris, et al.
Published: (2022-04-01) -
Handling missing values in patient-reported outcome data in the presence of intercurrent events
by: Doranne Thomassen, et al.
Published: (2025-03-01) -
Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial
by: Isabelle R. Weir, et al.
Published: (2024-03-01)